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tionnaire was supplemented with a generic instrument, the
EuroQol. The aim of the study was to measure the quality
of life depending upon severity level of the illness.
METHODS: Adult asthma patients treated in 23 pneu-
mologic ambulatory care units were randomly selected
and asked to fill out both the FLA and the EuroQol ques-
tionnaires. Separate analyses of the results were carried
out for each patient severity level; they covered the aver-
age values of the subscales, the correlation and the inter-
nal reliability of the questionnaires.
RESULTS: The quality of life of asthma patients corre-
lates strongly to the respective severity level of the illness.
This applies to all the examined dimensions of health-
related quality of life. The patients of level 3 (serious
asthma) in particular achieve values far below average
when compared to the total population (42 out of 100,
according to EuroQol). By contrast, the subjective quality
of life of asthmatics in level 1 is only slightly reduced. The
correlation of the FLA subscales as well as of the Euro-
Qol values is high (0.74–0.97). 
CONCLUSIONS: The study makes clear that illness pro-
gression is associated with high losses of quality of life for
the patient. From a health-economic point of view, this is
important for the calculation of so-called intangible costs,
which are often not quantified in studies on the cost of
disease.
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Childhood asthma is a disease that affects not only pa-
tients but also the quality of life of their parents and care-
givers. The PACQLQ is a 13-item scale that was devel-
oped in English to measure this impact. Prior to use in an
international trial, the original questionnaire underwent
cultural adaptation giving rise to 19 language versions.
This cultural adaptation process involved the recruitment
of a QoL specialist in each country as supervisor of the
translation process. First, each QoL specialist discussed
the concepts of the original instrument with the developer
(EFJ). Native speakers then produced two independent
forward translations. These were reconciled and back-
translated twice into English. Finally, the translations
were tested on a sample target population through in-
depth interviews conducted by the senior translator and
asthma clinicians. Translation problems included finding
conceptual equivalents for typical English expressions
and constructions. For example, “to feel frustrated,” “to
feel upset,” and “irritable” either had no literal equiva-
lent or led to misinterpretation in some languages. The
item “Did you feel angry that your child has asthma?”—
the content of which was found inappropriate in most
countries—had to be changed to reflect an emotion more
commonly experienced by parents. Finally, the design and
the mode of administration of the questionnaire was some-
what problematic in countries where people are not used
to completing questionnaires and have a low level of edu-
cation. Before use in an international trial, rigorous cul-
tural adaptation was essential to produce cross-culturally
valid language versions of the PACQLQ. The comparison
of answers across countries will clarify whether the im-
pact of asthma on parents or caregivers is similar in all
countries. Measurement properties will also have to be
confirmed once clinical data are available.
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Antibiotic resistance is a growing problem in all coun-
tries. However, because the precise role of community
antibiotic prescribing is undefined, practitioners attribute
the problem to overuse of antibiotics by others.
METHODS: Case-control design with incident urine sam-
ples (no sample in previous 6 months) from the population
of Tayside from 1 July 1993 to 31 December 1995. Cases
were subjects from whom trimethoprim-resistant gram-
negative bacteria (TR) were isolated. Controls were sub-
jects whose samples grew trimethoprim-sensitive gram-
negative bacteria (TS) or showed no bacterial growth
(NG). Exposure to risk factors in each group was deter-
mined from the MEMO and DARTS record-linkage data-
bases. Logistic regression was used to identify independent
risk factors. Demographic variables were age, sex, socio-
economic status, and diabetes mellitus. Exposure variables
(in the previous 6 months) were hospitalization and dis-
pensing of the following drugs from community pharma-
cies: antibiotics, corticosteroids or estrogens.
RESULTS: Of the 9362 incident urine samples used, 380
were TR, 1073 TS, and 7909 NG. The most important
risk factors were: exposure to trimethoprim (odds ratio
[OR] 3.08; 95% CI 2.48–3.81) or other antibiotics (OR
1.43; CI 1.14–1.80). Additional independent risk factors
were age (OR 1.28 for every 10 years after the first dec-
ade; CI 1.23–1.35) and prior hospitalization (OR 1.38;
CI 1.07–1.79). However, 35% of the TR group had not
been exposed to antibiotics or been hospitalized in the
previous 6 months.
CONCLUSION: There was a strong link between trime-
thoprim resistance and community prescribing of trime-
thoprim or other antibiotics. However, prior hospitaliza-
tion was an independent risk factor, and 35% of cases
were not associated with either risk factor. These data
suggest that antibiotic resistance is multifactorial.
